Consistently, immunoblotting and real-time RT-PCR results showed that both protein (Figures 2(a) and 2(b)) and mRNA expression (Figure 2(c)) of IDO1 were significantly higher in the tumor tissues of stages II and III compared to that in normal lung tissues, and that it was highest in stage III tumors. Here, IDO1 is linked to neoplasm.